Timing of Initiation of First-line Antiretroviral Therapy

  • Authors: Marshall J. Glesby, MD, PhD; Timothy J. Wilkin, MD, MPH (More Info)
  • Section Editor: Joel E. Gallant, MD, MPH
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 4/1/16 (What's New)

Summary

  • Liver-related deaths were inversely associated with CD4+ cell counts in the D:A:D cohort study[Weber 2006]
    • Risk of liver-related death was significantly lower among patients with a recent CD4+ cell count ≥ 500 cells/mm3 vs CD4+ cell count of 350-499 cells/mm3
  • Both the US guidelines (Management Guidelines)[DHHS ART] and the British guidelines (Management Guidelines)[BHIVA ART] advise that HBV or HCV coinfection may be an indication for earlier ART initiation in some patients

    Action required

    Keywords: Cardiovascular Disease, Initial Antiretroviral Therapy, Pregnancy, Renal Complications, Special Populations, Viral Hepatitis Coinfection

    ©2020 Clinical Care Options, LLC. All Rights Reserved.

    The materials published via inPractice® reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.